CSCs appear to hijack signaling pathways (e.g., GPCR) and mechanisms that regulate normal stem cells, adapting the ability to self-renew and thereby regenerating tumors after anti-cancer treatment [16,17]. This evidence concerns the gene LGR6 and cancer.